Illumina, Inc. - Common Stock (NQ:ILMN)

269.42 +0.02 (+0.01%)

Delayed Quote Updated: 4:00 PM EDT, Oct 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

40 41 Next >

Abbott Laboratories Finalizes $21 Billion Acquisition of Exact Sciences, Redefining the Future of Cancer Diagnostics

March 23, 2026

CHICAGO — In a move that fundamentally reshapes the global diagnostics landscape, Abbott Laboratories (NYSE: ABT) officially completed its $21 billion acquisition of Exact Sciences (NASDAQ: EXAS)...

Via MarketMinute

Topics Supply Chain

Life Sciences Tools & Services Stocks Q4 Earnings: Illumina (NASDAQ:ILMN) Firing on All Cylinders

March 17, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and it...

Via StockStory

Topics Artificial Intelligence

ADS and Gamma Scientific Release Joint White Paper on Practical Path to NHTSA ADB Compliance

March 17, 2026

Via PRLog

Illumina Inc (NASDAQ:ILMN) Stock Falls Despite Q4 Earnings Beat on Cautious 2026 Outlook ↗

February 05, 2026

Via Chartmill

Topics Earnings

Illumina Stock Sees RS Rating Jump To 82 ↗

March 16, 2026

One key metric to look for in a stock is an 80-plus Relative Strength Rating. Illumina stock cleared that benchmark Monday, jumping to 82.

Via Investor's Business Daily

3 Profitable Stocks with Open Questions

March 09, 2026

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...

Via StockStory

Life Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers

March 05, 2026

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its ...

Via StockStory

Topics Artificial Intelligence

Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB)

March 03, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at PacBio (NASDAQ:PACB) and its ...

Via StockStory

Topics Artificial Intelligence

The "Flight to Quality": Thermo Fisher’s Q4 Beat and Dividend Hike Cement Defensive Leadership for 2026

February 27, 2026

WALTHAM, MA — In a market defined by shifting geopolitical alliances and a renewed "flight to quality," Thermo Fisher Scientific (NYSE:TMO) has once again asserted its dominance as the bedrock of the...

Via MarketMinute

Topics Earnings Economy World Trade

What a $75 Million Exit From MDU Might Signal Amid a 24% One-Year Rally ↗

February 26, 2026

MDU Resources Group supplies regulated utilities and construction services across the U.S., with consistent revenue and a stable dividend.

Via The Motley Fool

Topics Energy

1 Healthcare Stock Worth Your Attention and 2 Facing Challenges

February 12, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only...

Via StockStory

Topics Stocks

5 Insightful Analyst Questions From Illumina’s Q4 Earnings Call

February 12, 2026

Illumina’s fourth quarter was marked by strong performance in its clinical consumables business, with management citing 20% year-over-year growth outside China as a key driver. CEO Jacob Thaysen...

Via StockStory

Topics Earnings

10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect

February 10, 2026

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings this Thursday after market hours. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence World Trade

PacBio Earnings: What To Look For From PACB

February 10, 2026

Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results this Thursday after market hours. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence World Trade

Could Nvidia Be the Best Way to Play the AI Boom in 2026? ↗

February 06, 2026

Nvidia was propelled to its current highs by the development of AI, but is it still one of the best ways to play it?

Via The Motley Fool

Topics Artificial Intelligence

Harvard’s PopEVE AI Cracks the Code of Rare Diseases: Ending the ‘Diagnostic Odyssey’ for Millions

February 06, 2026

In a landmark achievement for computational biology, researchers from Harvard Medical School and the Centre for Genomic Regulation (CRG) have unveiled PopEVE, a groundbreaking artificial intelligence...

Via TokenRing AI

Topics Artificial Intelligence

The Great AI Land Grab: Why Tech Giants are Paying Billions for Talent While Deal Volumes Sink

February 06, 2026

As of February 6, 2026, the technology sector is witnessing a paradoxical shift in the mergers and acquisitions (M&A) landscape. While the sheer number of transactions has hit an eight-year plateau,...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Molina Healthcare, Coty, Illumina, Amazon And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

February 06, 2026

Via Benzinga

ILMN Q4 Deep Dive: Clinical Consumables Growth, Multiomics Expansion, and Margin Momentum

February 06, 2026

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year to $1.16 billion. The company’s full-year revenue guidance of $4.55 billion...

Via StockStory

Illumina (ILMN) Q4 2025 Earnings Call Transcript ↗

February 05, 2026

Illumina (ILMN) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Illumina (NASDAQ:ILMN) Reports Bullish Q4 CY2025

February 05, 2026

Via StockStory

SBIR Eligibility Requirements: Small Business Qualification Guide Released

February 05, 2026

Via Press Release Distribution Service

Topics Intellectual Property

Cold Chain, High Stakes: A Deep Dive into Azenta’s (AZTA) Life Sciences Transformation

February 05, 2026

Date: February 5, 2026 Introduction In the high-stakes world of life sciences, the "cold chain" is the invisible backbone of modern medicine. From the development of mRNA vaccines to the emerging...

Via Finterra

Topics Artificial Intelligence Earnings Economy

Illumina (ILMN) Reports Q4: Everything You Need To Know Ahead Of Earnings

February 03, 2026

Genomics company Illumina (NASDAQ:ILMN) will be reporting results this Thursday after market close. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

The Analyst Verdict: Illumina In The Eyes Of 15 Experts ↗

January 26, 2026

Via Benzinga

The Silicon Ceiling Shatters: S&P 500’s Historic Ascent Past 5,300 and the AI Anchor

January 23, 2026

In a definitive display of market resilience, the S&P 500 (CME:GSPC) achieved a landmark milestone in May 2024, crossing the 5,300 threshold for the first time in history. This surge, culminating in a...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years ↗

January 22, 2026

Via Benzinga

Life Sciences Tools & Services Stocks Q3 Teardown: Illumina (NASDAQ:ILMN) Vs The Rest

January 21, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers.

Via StockStory

Topics Artificial Intelligence

Illumina Gets Medicare Boost for Cancer Test, Shares Climb ↗

January 20, 2026

Illumina shares rose after Medicare approved reimbursement for its FDA-approved cancer test, a move expected to drive growth.

Via Benzinga

3 Cash-Producing Stocks with Open Questions

January 18, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

40 41 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.